VM

Vanessa Malier

Managing Partner at Kurma Partners

Greater Paris Metropolitan Region

Overview

Work Experience

KP

Kurma Partners

  • Managing Partner

    2015 - 2023

    Kurma Partners/Eurazeo is a venture capital firm with €700m in asset under managment. I invested in and served on the Board of Asceneuron, Corlieve as a Chairman, acquired by uniQure, IO Biotech (IOBT), Step Pharma as a Chairman then Board member, Vivet Therapeutics and Xeltis.

  • Partner

    2013 - 2014

I

Ipsen

  • Vice President, R&D Strategic Planning

    2011 - 2013

  • Senior Director, Corporate Business Development

    2011 - 2011

  • Director, Corporate Business Development Oncology

    2008 - 2011

  • Adenuric Project Leader & International Product Manager, Corporate Strategic Marketing

    2005 - 2008

  • GastroEnterology Strategy Team Leader

    2004 - 2005

  • Strategic Advisor to the CEO

    2003 - 2005

DAS, Inc.

  • Business Development Manager

    1999 - 2003

CDC Entreprises Innovation

  • Analyst - Health Care

    1998 - 1999

Education

Investments

Step Pharma

Seed

Total Funding: $61M

IO Biotech

Series B

Total Funding: $150M

Corlieve Therapeutics

Seed

Total Funding:

Relevant Websites